Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human ...
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan.
The race to increase human life span through biotech just got tighter. Retro Biosciences, the AI-powered company whose mission is to develop therapies that reverse age-related disease, has just ...
Retro Biosciences, a startup that aims to use AI to aid in drug development, is reportedly raising $1 billion to support its research, with investors including OpenAI, which has previously backed ...
Retro Biosciences Inc., a startup using artificial intelligence to discover new drugs, is reportedly raising $1 billion in funding to support its research. The Financial Times today cited sources ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission ...
OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan. Altman ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results